IP Library Granted Patent US 8,147,851
Granted Patent B2
US 8,147,851 · App. 11/056,008 · Granted Apr 3, 2012

Treating eczema and/or psoriasis

Assignee: Lypanosys Pte Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,147,851
App. No.
11/056,008
Granted
Apr 3, 2012
Kind
B2
Abstract

The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.

Claims (11)

1. A method of treatment of eczema in a mammal, comprising administering or having self-administered to said mammal an effective amount of a medicament consisting of cetyl myristate, cetyl palmitate and one or both of an excipient and a diluent, wherein said administration is oral administration.

2. The method as claimed in claim 1 wherein said cetyl myristate is present in an amount of from 50 to 98% w/w of the composition.

3. The method as claimed in claim 1 wherein cetyl myristate and cetyl palmitate are present in the composition in a ratio of 95:5 by weight.

4. The method as claimed in claim 2 wherein said composition is a capsule.

5. The method as claimed in claim 3 wherein said composition is a capsule.

6. The method as claimed in claim 1 wherein said mammal is a human being suffering from eczema.

7. A method of treatment of eczema in a mammal, comprising administering or having self-administered to said mammal an effective amount of a medicament for relief of a symptom of eczema, wherein said medicament consists of cetyl myristate, and cetyl palmitate and one or both of an excipient and a diluent, and wherein said administration is oral administration.

8. The method of claim 7 , wherein said administering is effective in reducing itching associated with said eczema.

9. The method of claim 7 , wherein said administering is effective in healing eczema lesions.

10. The method of claim 7 , wherein said administering is effective in returning skin to a smooth unblemished appearance.

11. The method of claim 7 , wherein said mammal is using a steroid at the onset of said administering, and said method further comprises reducing use of the steroid by said mammal.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2011
From: MERACOL CORPORATION LIMITED
To: MERACOL INVESTMENTS LIMITED
Reel/Frame 026883/0278 →
CHANGE OF NAME Recorded Sep 9, 2011
From: MERACOL INVESTMENTS LIMITED
To: LYPANOSYS LIMITED
Reel/Frame 026883/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2011
From: LYPANOSYS LIMITED
To: LYPANOSYS PTE LIMITED
Reel/Frame 026883/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2010
From: MEAKIN, TIMOTHY DAVID; HEATLEY, CRAIG LEONARD; CADWALLADER, DIANNE
To: MERACOL CORPORATION LIMITED
Reel/Frame 024739/0021 →
Priority Claims (2)
NZ 504525 · May 12, 2000 · national
NZ 507228 · Sep 28, 2000 · national
Continuity (2)
Division 10275269
Related Publication 20050137257A1 · Jun 23, 2005